{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 13:40:59", "close_timestamp": 1637070059476, "created": "16/11/2021 13:41:01", "department": "Management Studies", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "cbaadaf6-c137-4bd1-8a07-6521ced24ae6", "open_date_time": "2021-10-16 13:34:33", "open_timestamp": 1637069673493, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "It seems that an anti-parasitic drug has been around and has capability to be effective at killing covid within 48 hours. ", "task_condition": "text", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 385983, "what": "Use/effectiveness of anti-parasitic drugs agains covid", "when_happened": "current_week", "where_location": "Australia/Melbourne", "who": "Peter Doherty, Dr Kyle Wagstaff, FDA, ", "why": "Highlights the effectiveness and offers an alternative solution so an issue that has very little information. "}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 13:51:54", "close_timestamp": 1637070714301, "created": "16/11/2021 13:51:55", "department": "Management Studies", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "6fce6636-2cf7-4ba4-b3cb-3e84b1ca1bad", "open_date_time": "2021-10-16 13:46:6", "open_timestamp": 1637070366058, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "Vaccines taker a long time to research, develop and test. With the help of multiple countries, a larger budget and quicker approval, it can take a lot less time to develop.", "task_condition": "viz", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 348243, "what": "Development of vaccines", "when_happened": "current_month", "where_location": "India, mexico, vaccination test sites", "who": "Multiple countries", "why": "Vaccinations are a long process when it comes to development. Due to the complications, it means its harder when operating under a rushed time schedule. "}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 13:45:58", "close_timestamp": 1637070358151, "created": "16/11/2021 13:45:58", "department": "Management Studies", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "e163a618-81a1-4a41-bf22-18447f0468a1", "open_date_time": "2021-10-16 13:41:21", "open_timestamp": 1637070081324, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Professor theorises that a potential solution to handling the pandemic, is to use a specific, already available current medication, which should be effective", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 276827, "what": "Not waiting for a vaccine to be readily available, instead using current hypothetical treatment ", "when_happened": "few_weeks_ago", "where_location": "Australia ", "who": "Kyleie Wagstaff, Proff Borody, ", "why": "Shows the view of someone who is providing an alternative route, aside from waiting for a vaccine"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 13:55:36", "close_timestamp": 1637070936358, "created": "16/11/2021 13:55:36", "department": "Management Studies", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "c57570cc-fbf5-43c7-9dcc-d5815d70d320", "open_date_time": "2021-10-16 13:52:2", "open_timestamp": 1637070722592, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Japan have started to approve medication for covid, the first to do so. Its becoming increasingly important as rates increase worldwide", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 213766, "what": "Japan have approved a medication against covid", "when_happened": "current_week", "where_location": "Japan", "who": "Dr Osamu Okuda", "why": "Japan being globally the first to make a move on covid medication"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 14:4:16", "close_timestamp": 1637071456616, "created": "16/11/2021 14:04:18", "department": "Management Studies", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "5bc2b2c1-b9e5-4680-9326-e65f6f37f12e", "open_date_time": "2021-10-16 13:55:46", "open_timestamp": 1637070946277, "summary": "After multiple acquisitions, Pfizer have been able to develop a vaccine. Shown to be effective against multiple strains, it has been FDA approved. The shelf life is shown to be effective for up to 30 days, countries have been factoring in emergency jabs for teens. Additionally, they been looking at long-term plans, involving jabs with children, implying that Pfizer will be used for a while. The sales have been at a record high, implying that theres been a high amount of faith in Pfizer by a fair amount of countries.", "task_condition": "text", "task_key": "pfizer", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 510339}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_4", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-16 14:14:37", "close_timestamp": 1637072077255, "created": "16/11/2021 14:14:39", "department": "Management Studies", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "ac281e5d-c7bb-4f01-999e-24d368587810", "open_date_time": "2021-10-16 14:4:36", "open_timestamp": 1637071476996, "summary": "Astrazeneca, pharma rival similar to Pfizer, have also started to work on a vaccine for covid. Reports of early stages of trials seemed to have negative feedback, but they have started to roll it out globally. Multiple countries have raised issues, India delayed the shipment of the vaccine, the EU have started a lawsuit against Astrazeneca about the potential side effects. Studies are starting to show a correlation between the vaccine and blood clots. Despite all this, profits and sales have been much higher than expected, with revenue up from 15% from last year. ", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "under_graduate_year_1", "time_taken_in_seconds": 600259}}}